don't fret the intraday volatility and short term s/price movements
RAP is a big picture stock pursuing a potentially huge global market opportunity
in some ways the hard work has been done ---> 3 top shelf hospitals are signed up and are ready to participate in the SMARTCOUGH-C study. the study will proceed, don't worry about that
but for now it's a waiting game ... buy, hold or sell ... each to their own
if RAP is ultimately successful in its first FDA submission in 2017, then that will immediately open any number of potential doors and pave the way for a roll-out of further FDA submissions
and while we wait i'm reminded of these little snippets from the 18 october '16 investor presentation:
View attachment 365234
View attachment 365237
View attachment 365240
View attachment 365243
View attachment 365270
View attachment 365273
and while the main game is focussed on commencing the US study, rockboy can see at least one or more potential announcements that could be made at any time so rockboy chooses to sit tight and looks forward to expecting the unexpected w RAP